Parenteral Ascorbic Acid in Allogeneic HCT Recipients Is Safe and Ameliorates the Cytokine Milieu and Endothelial Injury Following Myeloablative Conditioning

Publication/Presentation Date

3-2020

Volume

26

Issue

3

First Page

139

Last Page

140

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Lehigh Valley Topper Cancer Institute

Document Type

Article

Share

COinS